Cell culture systems and drug targets for hepatitis a virus infection

Tatsuo Kanda; Reina Sasaki; Ryota Masuzaki; Naoki Matsumoto; Masahiro Ogawa; Mitsuhiko Moriyama

doi:10.3390/v12050533

Cell culture systems and drug targets for hepatitis a virus infection

Tatsuo Kanda, Reina Sasaki, Ryota Masuzaki, Naoki Matsumoto, Masahiro Ogawa, Mitsuhiko Moriyama

医学部

Nihon University

研究成果: ジャーナルへの寄稿 › 総説 › 査読

19 被引用数 (Scopus)

抄録

Hepatitis A virus (HAV) infection is one of the major causes of acute hepatitis, and this infection occasionally causes acute liver failure. HAV infection is associated with HAV-contaminated food and water as well as sexual transmission among men who have sex with men. Although an HAV vaccine has been developed, outbreaks of hepatitis A and life-threatening severe HAV infections are still observed worldwide. Therefore, an improved HAV vaccine and anti-HAV drugs for severe hepatitis A should be developed. Here, we reviewed cell culture systems for HAV infection, and other issues. This review may help with improving the HAV vaccine and developing anti-HAV drugs.

本文言語	英語
論文番号	v12050533
ジャーナル	Viruses
巻	12
号	5
DOI	https://doi.org/10.3390/v12050533
出版ステータス	出版済み - 5月 2020

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

文献へのアクセス

10.3390/v12050533

他のファイルとリンク

Scopusの出版物のリンク

引用スタイル

@article{89c6cca1625446249068f164990f70da,

title = "Cell culture systems and drug targets for hepatitis a virus infection",

abstract = "Hepatitis A virus (HAV) infection is one of the major causes of acute hepatitis, and this infection occasionally causes acute liver failure. HAV infection is associated with HAV-contaminated food and water as well as sexual transmission among men who have sex with men. Although an HAV vaccine has been developed, outbreaks of hepatitis A and life-threatening severe HAV infections are still observed worldwide. Therefore, an improved HAV vaccine and anti-HAV drugs for severe hepatitis A should be developed. Here, we reviewed cell culture systems for HAV infection, and other issues. This review may help with improving the HAV vaccine and developing anti-HAV drugs.",

keywords = "50 UTR, Anti-HAV, Drug screening, HAV, Huh7, IRES, PLC/PRF/5, Subgenomic replicon, Vaccine",

author = "Tatsuo Kanda and Reina Sasaki and Ryota Masuzaki and Naoki Matsumoto and Masahiro Ogawa and Mitsuhiko Moriyama",

note = "Publisher Copyright: {\textcopyright} 2020 by the authors.",

year = "2020",

month = may,

doi = "10.3390/v12050533",

language = "English",

volume = "12",

journal = "Viruses",

issn = "1999-4915",

number = "5",

}

TY - JOUR

T1 - Cell culture systems and drug targets for hepatitis a virus infection

AU - Kanda, Tatsuo

AU - Sasaki, Reina

AU - Masuzaki, Ryota

AU - Matsumoto, Naoki

AU - Ogawa, Masahiro

AU - Moriyama, Mitsuhiko

PY - 2020/5

Y1 - 2020/5

N2 - Hepatitis A virus (HAV) infection is one of the major causes of acute hepatitis, and this infection occasionally causes acute liver failure. HAV infection is associated with HAV-contaminated food and water as well as sexual transmission among men who have sex with men. Although an HAV vaccine has been developed, outbreaks of hepatitis A and life-threatening severe HAV infections are still observed worldwide. Therefore, an improved HAV vaccine and anti-HAV drugs for severe hepatitis A should be developed. Here, we reviewed cell culture systems for HAV infection, and other issues. This review may help with improving the HAV vaccine and developing anti-HAV drugs.

AB - Hepatitis A virus (HAV) infection is one of the major causes of acute hepatitis, and this infection occasionally causes acute liver failure. HAV infection is associated with HAV-contaminated food and water as well as sexual transmission among men who have sex with men. Although an HAV vaccine has been developed, outbreaks of hepatitis A and life-threatening severe HAV infections are still observed worldwide. Therefore, an improved HAV vaccine and anti-HAV drugs for severe hepatitis A should be developed. Here, we reviewed cell culture systems for HAV infection, and other issues. This review may help with improving the HAV vaccine and developing anti-HAV drugs.

KW - 50 UTR

KW - Anti-HAV

KW - Drug screening

KW - HAV

KW - Huh7

KW - IRES

KW - PLC/PRF/5

KW - Subgenomic replicon

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=85084795094&partnerID=8YFLogxK

U2 - 10.3390/v12050533

DO - 10.3390/v12050533

M3 - Review article

C2 - 32408660

AN - SCOPUS:85084795094

SN - 1999-4915

VL - 12

JO - Viruses

JF - Viruses

IS - 5

M1 - v12050533

ER -

Cell culture systems and drug targets for hepatitis a virus infection

抄録

UN SDG

文献へのアクセス

他のファイルとリンク

フィンガープリント

引用スタイル